The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart pump.

Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke.

Irvine: Johnson & Johnson MedTech, an emerging leader in neurovascular care, has announced the launch of the CEREGLIDE 92 ...

Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...

Relocating manufacturing would require substantial capital investment, but the timespan for the president’s new tariffs is ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...

TECLens Inc., a Stamford-based clinical-stage ophthalmic medical device company, said Tuesday it raised $9.3 million in a ...

Johnson & Johnson (NYSE:JNJ), the New Jersey-based healthcare company, is planning to sell its stroke care business, ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

Johnson & Johnson aims to streamline operations by selling its stroke care business, Cerenovus, valued at $1B+.

Have you ever thought about how medical devices designed to improve lives can sometimes cause harm instead? This became evident in August 2024, when a landmark settlement in England saw 140 women ...